Ota et al. developed a novel PIP conjugated with a DNA alkylating agent targeting the F1174L-mutated ALK gene, which proved to be cytotoxic against NB cells and showed antitumor activity in mice models [69]. The gene discussed is ALK; the disease is neuroblastoma.